168 related articles for article (PubMed ID: 30735509)
1. Pyruvate Kinase M2 serves as blockade for nucleosome repositioning and abrogates Chd7 remodeling activity.
Verma K; Patel A
PLoS One; 2019; 14(2):e0211515. PubMed ID: 30735509
[TBL] [Abstract][Full Text] [Related]
2. The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities.
Manning BJ; Yusufzai T
J Biol Chem; 2017 Jul; 292(28):11927-11936. PubMed ID: 28533432
[TBL] [Abstract][Full Text] [Related]
3. A Novel N-terminal Region to Chromodomain in CHD7 is Required for the Efficient Remodeling Activity.
Lee E; Kang C; Purhonen P; Hebert H; Bouazoune K; Hohng S; Song JJ
J Mol Biol; 2021 Sep; 433(18):167114. PubMed ID: 34161779
[TBL] [Abstract][Full Text] [Related]
4. Mutant Isocitrate Dehydrogenase 1 Disrupts PKM2-β-Catenin-BRG1 Transcriptional Network-Driven CD47 Expression.
Gowda P; Patrick S; Singh A; Sheikh T; Sen E
Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463646
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate kinase M2 interacts with DNA damage-binding protein 2 and reduces cell survival upon UV irradiation.
Xie X; Wang M; Mei J; Hu F; Ding F; Lv L
Biochem Biophys Res Commun; 2015 Nov; 467(2):427-33. PubMed ID: 26410533
[TBL] [Abstract][Full Text] [Related]
6. Histone modification as a reflection of metabolism.
Suganuma T; Workman JL
Cell Cycle; 2016; 15(4):481-2. PubMed ID: 26726751
[No Abstract] [Full Text] [Related]
7. Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor.
Matsuda S; Adachi J; Ihara M; Tanuma N; Shima H; Kakizuka A; Ikura M; Ikura T; Matsuda T
Nucleic Acids Res; 2016 Jan; 44(2):636-47. PubMed ID: 26405201
[TBL] [Abstract][Full Text] [Related]
8. The multifaceted regulation and functions of PKM2 in tumor progression.
Li Z; Yang P; Li Z
Biochim Biophys Acta; 2014 Dec; 1846(2):285-96. PubMed ID: 25064846
[TBL] [Abstract][Full Text] [Related]
9. Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders.
Bouazoune K; Kingston RE
Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19238-43. PubMed ID: 23134727
[TBL] [Abstract][Full Text] [Related]
10. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
[TBL] [Abstract][Full Text] [Related]
11. Lack of Evidence for PKM2 Protein Kinase Activity.
Hosios AM; Fiske BP; Gui DY; Vander Heiden MG
Mol Cell; 2015 Sep; 59(5):850-7. PubMed ID: 26300261
[TBL] [Abstract][Full Text] [Related]
12. Single-molecule nucleosome remodeling by INO80 and effects of histone tails.
Schwarz M; Schall K; Kallis E; Eustermann S; Guariento M; Moldt M; Hopfner KP; Michaelis J
FEBS Lett; 2018 Feb; 592(3):318-331. PubMed ID: 29331030
[TBL] [Abstract][Full Text] [Related]
13. Moderate DNA damage promotes metabolic flux into PPP via PKM2 Y-105 phosphorylation: a feature that favours cancer cells.
Kumar B; Bamezai RN
Mol Biol Rep; 2015 Aug; 42(8):1317-21. PubMed ID: 25840825
[TBL] [Abstract][Full Text] [Related]
14. HERVH-derived lncRNAs negatively regulate chromatin targeting and remodeling mediated by CHD7.
Hsieh FK; Ji F; Damle M; Sadreyev RI; Kingston RE
Life Sci Alliance; 2022 Jan; 5(1):. PubMed ID: 34663690
[No Abstract] [Full Text] [Related]
15. Genome-wide nucleosome specificity and function of chromatin remodellers in ES cells.
de Dieuleveult M; Yen K; Hmitou I; Depaux A; Boussouar F; Bou Dargham D; Jounier S; Humbertclaude H; Ribierre F; Baulard C; Farrell NP; Park B; Keime C; Carrière L; Berlivet S; Gut M; Gut I; Werner M; Deleuze JF; Olaso R; Aude JC; Chantalat S; Pugh BF; Gérard M
Nature; 2016 Feb; 530(7588):113-6. PubMed ID: 26814966
[TBL] [Abstract][Full Text] [Related]
16. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
[TBL] [Abstract][Full Text] [Related]
17. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
[TBL] [Abstract][Full Text] [Related]
18. Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation.
Coassolo S; Davidson G; Negroni L; Gambi G; Daujat S; Romier C; Davidson I
Nat Commun; 2021 Mar; 12(1):1718. PubMed ID: 33741961
[TBL] [Abstract][Full Text] [Related]
19. PKM2, a potential target for regulating cancer.
Li YH; Li XF; Liu JT; Wang H; Fan LL; Li J; Sun GP
Gene; 2018 Aug; 668():48-53. PubMed ID: 29775756
[TBL] [Abstract][Full Text] [Related]
20. Nucleosome remodeling: one mechanism, many phenomena?
Längst G; Becker PB
Biochim Biophys Acta; 2004 Mar; 1677(1-3):58-63. PubMed ID: 15020046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
